SEC Form 4 · accession 0001209191-19-018793
ACORDA THERAPEUTICS INC · ACOR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peder Jensen
Director
Period of report
Mar 8, 2019
Accepted (ET)
Mar 12, 2019 · 4:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001008848
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Employee Stock OptionF1 | $13.51 | Mar 8, 2019 | A | 10,000 | A | — | Mar 8, 2029 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to this option will vest in full on March 8, 2020.